7XC Stock Chart & Stats
€34.00
€1.00(2.70%)
At close: 4:00 PM EDT
€34.00
€1.00(2.70%)
Day’s Range― - ―
52-Week Range€29.00 - €38.00
Previous CloseN/A
Volume0.00
Average Volume (3M)6.00
Market Cap
€7.67B
Enterprise Value€10.63B
Total Cash (Recent Filing)€49.27M
Total Debt (Recent Filing)€1.21B
Price to Earnings (P/E)22.6
Beta0.24
Next Earnings
Nov 05, 2026EPS Estimate
0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.61
Shares Outstanding236,293,200
10 Day Avg. Volume3
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)1.82
Price to Sales (P/S)15.45
P/FCF Ratio19.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€39.29Price Target Upside15.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)1.39
Revenue Forecast (FY)€458.62M
Bulls Say, Bears Say
Bulls Say
Raised Earnings GuidanceRaised full-year guidance and double-digit projected growth indicate strong operating momentum and management confidence in the portfolio. If delivered, higher recurring FFO and FAD should support internally funded growth, dividend capacity, and stronger earnings power over the next several quarters.
Liquidity And LeverageSubstantial liquidity, low net leverage, and high fixed-charge coverage provide meaningful financial flexibility for acquisitions and refinancing. This balance-sheet strength reduces dependence on near-term operating cash flow and improves CareTrust’s ability to pursue growth through changing healthcare real estate conditions.
Operator And Portfolio QualityAbove-industry operator quality supports tenant performance and the durability of contractual rent collections, which are central to CareTrust’s healthcare real estate model. Stronger operators may also improve portfolio resilience and create better conditions for sustained lease coverage and long-term asset value.
Bears Say
SHOP CompetitionGreater competition in the SHOP market can reduce acquisition yields and make growth opportunities less attractive on a risk-adjusted basis. Persistent pricing pressure may limit CareTrust’s ability to deploy capital accretively, requiring stricter underwriting or a slower expansion pace in this segment.
Funding And Guidance Execution RiskReliance on unsettled equity proceeds and several operating and currency assumptions creates execution risk around the forecast. Delays in funding, repayments, investment timing, or foreign-exchange conditions could reduce expected per-share growth and make planned capital deployment less predictable.
Financing Receivable Conversion UncertaintyLong-dated purchase options create uncertainty over when financing receivables may convert into owned triple-net assets. Although management views these loans as high quality, delayed or uneven exercise timing could defer portfolio growth, asset conversion, and the related earnings benefits.
CareTrust REIT News
7XC FAQ
What was CareTrust REIT’s price range in the past 12 months?
CareTrust REIT lowest stock price was €29.00 and its highest was €38.00 in the past 12 months.
What is CareTrust REIT’s market cap?
CareTrust REIT’s market cap is €7.67B.
When is CareTrust REIT’s upcoming earnings report date?
CareTrust REIT’s upcoming earnings report date is Nov 05, 2026 which is in 5 days.
How were CareTrust REIT’s earnings last quarter?
CareTrust REIT released its earnings results on Aug 06, 2026. The company reported €0.339 earnings per share for the quarter, missing the consensus estimate of €0.343 by -€0.004.
Is CareTrust REIT overvalued?
According to Wall Street analysts CareTrust REIT’s price is currently Undervalued.
Does CareTrust REIT pay dividends?
CareTrust REIT does not currently pay dividends.
What is CareTrust REIT’s EPS estimate?
CareTrust REIT’s EPS estimate is 0.36.
How many shares outstanding does CareTrust REIT have?
CareTrust REIT has 236,293,200 shares outstanding.
What happened to CareTrust REIT’s price movement after its last earnings report?
CareTrust REIT reported an EPS of €0.339 in its last earnings report, missing expectations of €0.343. Following the earnings report the stock price went down -0.562%.
Which hedge fund is a major shareholder of CareTrust REIT?
Currently, no hedge funds are holding shares in DE:7XC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareTrust REIT Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€39.29 (15.55% Upside)
€39.29 (15.55% Upside)
Blogger Sentiment
Bullish
DE:7XC Sentiment 85%
Sector Average 62%
Sector Average 62%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
10.26%
12-Months-Change
Fundamentals
Return on Equity
8.54%
Trailing 12-Months
Asset Growth
27.33%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CareTrust REIT
CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, seniors' housing complexes, and other related medical real estate. It maintains a broad, nationwide portfolio of assets, all under long-term net lease agreements with an expanding group of reputable operators. CareTrust REIT is actively pursuing strategic growth across the United States, leveraging both external investments and organic expansion opportunities.
7XC Company Deck
7XC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive on operational and financial performance: record quarterly investments, robust YTD deployment (~$1.5B), double-digit per-share growth guidance, materially higher normalized FFO/FAD and conservative leverage with ample liquidity. Offsetting items are focused and tactical: competitive pressures and cap rate compression in the SHOP market, modest pricing premium on a large U.K. buy, reliance on unsettled equity forward proceeds and certain guidance assumptions, and multi-year uncertainty around financing receivable purchase options. Overall the strengths (record investment activity, significant FFO/FAD growth, strong balance sheet and operator quality) materially outweigh the select execution and market risks discussed.View all DE:7XC earnings summaries7XC Stock 12 Month Forecast
Average Price Target
€39.29
▲(15.55% Upside)
Technical Analysis
LTC Properties
―
National Health Investors
―
Omega Healthcare
―
Sabra Healthcare REIT
―
Strawberry Fields REIT Inc
―